Header cover image

Malaysian (KLSE) Clinical Research and Equipment Industry Analysis

UpdatedDec 26, 2024
DataAggregated Company Financials
Companies1
  • 7D1.4%
  • 3M2.8%
  • 1Y-17.0%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has risen 5.9%, driven by gains from every company within the industry. In contrast, the industry has lost 20% in the last 12 months.

Industry Valuation and Performance

Has the Malaysian Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 26 Dec 2024RM 50.1mRM 8.9m-RM 7,376,906.00n/a-6.8x5.6x
Sat, 23 Nov 2024RM 45.3mRM 9.7m-RM 7,896,906.00n/a-5.7x4.6x
Mon, 21 Oct 2024RM 46.7mRM 9.7m-RM 7,896,906.00n/a-5.9x4.8x
Wed, 18 Sep 2024RM 50.8mRM 9.7m-RM 7,896,906.00n/a-6.4x5.2x
Fri, 16 Aug 2024RM 51.5mRM 10.7m-RM 17,594,906.00n/a-2.9x4.8x
Sun, 14 Jul 2024RM 54.9mRM 10.7m-RM 17,594,906.00n/a-3.1x5.1x
Tue, 11 Jun 2024RM 57.6mRM 9.6m-RM 19,048,906.00n/a-3x6x
Thu, 09 May 2024RM 56.3mRM 9.6m-RM 19,048,906.00n/a-3x5.9x
Sat, 06 Apr 2024RM 57.6mRM 9.6m-RM 19,296,000.00n/a-3x6x
Mon, 04 Mar 2024RM 61.7mRM 9.6m-RM 19,296,000.00n/a-3.2x6.4x
Wed, 31 Jan 2024RM 61.1mRM 8.4m-RM 14,246,000.00n/a-4.3x7.3x
Fri, 29 Dec 2023RM 60.4mRM 8.4m-RM 14,246,000.00n/a-4.2x7.2x
Sun, 26 Nov 2023RM 63.8mRM 8.4m-RM 14,246,000.00n/a-4.5x7.6x
Tue, 24 Oct 2023RM 68.6mRM 8.4m-RM 14,246,000.00n/a-4.8x8.2x
Thu, 21 Sep 2023RM 70.0mRM 8.4m-RM 14,246,000.00n/a-4.9x8.4x
Sat, 19 Aug 2023RM 60.4mRM 12.5mRM 781.0k77.3x77.3x4.8x
Mon, 17 Jul 2023RM 59.2mRM 12.5mRM 781.0k75.9x75.9x4.8x
Wed, 14 Jun 2023RM 61.2mRM 12.5mRM 781.0k78.4x78.4x4.9x
Fri, 12 May 2023RM 71.0mRM 16.9mRM 5.6m12.7x12.7x4.2x
Sun, 09 Apr 2023RM 74.9mRM 16.9mRM 5.6m13.4x13.4x4.4x
Tue, 07 Mar 2023RM 85.9mRM 16.9mRM 5.6m15.3x15.3x5.1x
Thu, 02 Feb 2023RM 99.0mRM 22.9mRM 7.8m12.7x12.7x4.3x
Sat, 31 Dec 2022RM 99.6mRM 22.9mRM 7.8m12.7x12.7x4.4x
Mon, 28 Nov 2022RM 93.2mRM 22.9mRM 7.8m11.9x11.9x4.1x
Wed, 26 Oct 2022RM 83.2mRM 28.4mRM 7.2m11.5x11.5x2.9x
Fri, 23 Sep 2022RM 88.8mRM 28.4mRM 7.2m12.3x12.3x3.1x
Sun, 21 Aug 2022RM 87.6mRM 22.0mRM 1.1m79x79x4x
Tue, 19 Jul 2022RM 132.9mRM 22.0mRM 1.1m120x119.9x6.1x
Thu, 16 Jun 2022RM 88.2mRM 22.0mRM 1.1m79.6x79.6x4x
Sat, 14 May 2022RM 88.8mRM 18.5m-RM 655,882.00n/a-135.4x4.8x
Mon, 11 Apr 2022RM 109.9mRM 18.5m-RM 655,882.00n/a-167.6x5.9x
Wed, 09 Mar 2022RM 98.1mRM 18.5m-RM 655,882.00n/a-149.6x5.3x
Fri, 04 Feb 2022RM 140.4mRM 11.0m-RM 3,220,882.00n/a-43.6x12.7x
Sun, 02 Jan 2022RM 144.1mRM 11.0m-RM 3,220,882.00n/a-44.7x13.1x
Price to Earnings Ratio

-44.7x


Total Market Cap: RM 144.1mTotal Earnings: -RM 3,220,882.00Total Revenue: RM 11.0mTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Clinical Research and Equipment Industry Price to Earnings3Y Average 0.4x20232024
Current Industry PE
    There is only one company in the Malaysian Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Revenues have also declined 6.9% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does Malaysian Clinical Research and Equipment compare with similar industries?

MY Market0.035%
Healthcare-1.51%
Life Sciences1.39%
Clinical Research and Equipment1.39%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MGRC Malaysian Genomics Resource Centre BerhadRM 0.372.8%
+RM 1.4m
-15.9%PS5.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MGRC

RM 0.37

Malaysian Genomics Resource Centre Berhad

7D

2.8%

1Y

-15.9%